Patrick John Finn - Feb 1, 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Commercial Officer
Signature
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
Stock symbol
TWST
Transactions as of
Feb 1, 2022
Transactions value $
-$23,246
Form type
4
Date filed
2/3/2022, 03:35 PM
Previous filing
Jan 26, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $6.53K +280 +0.64% $23.33 43.7K Feb 1, 2022 Direct
transaction TWST Common Stock Options Exercise $10.1K +379 +0.87% $26.66 44.1K Feb 1, 2022 Direct
transaction TWST Common Stock Sale -$39.9K -659 -1.49% $60.52 43.5K Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -379 -1.09% $0.00 34.5K Feb 1, 2022 Common Stock 379 $26.66 Direct F2
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -280 -1.4% $0.00 19.7K Feb 1, 2022 Common Stock 280 $23.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 16, 2021.
F2 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.